
    
      The purpose of this study is is to test for bioequivalence based on AUC0-24h and Cmax between
      Wosulin N and NovolinÂ® N.The study also compares the pharmacokinetic and pharmacodynamic
      profiles as well as assessing safety and local tolerability of the two insulin preparations
      in healthy subjects.
    
  